We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

ERBA MANNHEIM

Erba Mannheim is an IVD solutions provider focused on improving health outcomes in developing nations. Originally fou... read more Featured Products: More products

Download Mobile App





Erba Introduces XL Range of Fully Automated Clinical Chemistry Systems at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 08 Feb 2023

Erba Mannheim (London, UK) is introducing its latest XL range of fully automated clinical chemistry systems at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023. More...

At Medlab Middle East 2023, Erba is showcasing the XL range of four fully automated clinical chemistry systems that incorporate state-of-the-art features. These rugged and performance-oriented systems boost lab productivity and throughput, making them an essential part of any start-up, medium or advanced lab. They support a wide test menu spanning routine clinical chemistry, electrolytes, immunoassays and coagulation tests. The XL range includes the XL 1000 fully automated clinical chemistry analyzer that guarantees high resolution measurement with automatic sample conveyor for comfortable workflow in laboratories with high sample throughput. It also includes the XL 200 fully automated random access clinical chemistry analyzer having a throughput of 200 tests/hr (photometric test) and 400 tests/hr with ISE (Na/K/Cl/Li). Also part of the XL range is the XL 640 fully automated biochemistry analyzer with a throughput of 640 tests per hour that is powerful and robust enough to keep up with the heavy demands of everyday testing, as well as the XL 180 that is designed to give convenience and flexibility in operation and good quality reporting for small and medium-sized laboratories.

From its hematology line, Erba is highlighting the H360 automated 3-part differential hematology analyzer that can be used as a complete blood count analyzer by small laboratories or as a second instrument. Within its coagulation line, Erba is showcasing the ECL 105 single channel semi-automated system for small laboratories that performs measurements of all clotting assays as well as DDimer. With a color touch-screen and intuitive user interface, the ECL-105 is simple to use and ensures quality results. Also featuring at the show is the LAURA Smart urine strip reader which is an efficient and compact solution for routine chemical urinalysis. The equipment's semi-automatic technology facilitates the sample process, contributing to the correct diagnosis of patients. In addition, Erba is presenting the EC90 electrolyte analyzer featuring clean biosensor and maintenance-free technology. Designed for easy use, efficient operation and reliability, the EC90 has an analysis time of only 35 seconds.

Related Links:
Erba Mannheim 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
All-in-One Molecular System
AIO M160
Gold Member
Platelet Function Analyzer
PL-12
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Blood proteins measured years before diagnosis may signal future prostate cancer risk, including aggressive disease.(Image Credit: iStock)

Blood Proteins Reveal Signals Linked to Prostate Cancer Risk Years Before Diagnosis

Prostate cancer is the most commonly diagnosed cancer in men worldwide. While many tumors grow slowly, aggressive forms can be life-threatening, underscoring the need for earlier risk identification.... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image Credit: iStock

AI Tissue Analysis May Help Identify Missed Precancerous Colon Polyps

Colorectal cancer is diagnosed in an estimated 1.9 million people worldwide each year, often without symptoms in its early stages. Timely detection of precancerous lesions is therefore important, yet some... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: Beginning in 2027, Quest will provide access to the Onclarity Self-Collection Kit through clinician, health plan, and consumer-initiated testing channels, along with its patient service center network.

Collaboration to Expand Cervical Cancer Screening Access With At-Home HPV Collection

Cervical cancer is largely preventable with regular screening and early detection of human papillomavirus (HPV), the leading cause of the disease. Screening gaps persist, in part because traditional sample... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.